Search Results 391-400 of 17255 for egfr

  1. Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia - Mayo Clinic

    Serum creatinine > 1.5 x ULN or eGFR 160 mmHg and/or diastolic blood pressure > 95 mmHg). Baseline standard 12-lead ECG that demonstrates clinically ...

  2. Subcutaneous Furosemide In Acute Decompensated Heart Failure Pilot - Mayo Clinic

    Participation eligibility · Severe renal dysfunction (Estimated Glomerular Filtration Rate (eGFR)< 30 ml/min/1.73m2) · Requirement for inotropes (other than ...

  3. SURPASS: A Randomized, Double-Blind, Multicenter Study Of The Efficacy, Safety, And Tolerability Of Brincidofovir Versus Valganciclovir For The Prevention Of Cytomegalovirus (CMV) Disease In CMV Seropositive Kidney Transplant Recipients - Mayo Clinic

    14 days posttransplant eGFR > 10mL/min by the C-G equation; Able to ingest tablets. Exclusion Criteria: Multi organ transplant recipient; Plasma CMV PCR > LOD ...

  4. Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells - Mayo Clinic

    ... (eGFR less that 45 mL/min) and therefore cannot have a CT examination; Individuals not eligible for MRI and have a prior significant reaction to intravenous ...

  5. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Cirrhosis - Mayo Clinic

    Estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2 according to the Modification of Diet in Renal Disease equation;; Evidence of significant ...

  6. A study to test whether survodutide helps people with a liver disease called NASH/MASH who have cirrhosis - Mayo Clinic

    Impaired renal function, defined as estimated glomerular filtration rate (eGFR) 2x ULN as measured by the central laboratory at screening. Trial ...

  7. VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Tumors lack activating epidermal growth factor receptor (EGFR) mutations or ALK rearrangement (no EGFR or ALK testing is required if a subject has a KRAS ...

  8. A Phase 2 Trial Of ALN-APP In Patients With Cerebral Amyloid Angiopathy - Mayo Clinic

    * Has estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73m\^2 at Screening * Has recently received an investigational agent * Has had treatment ...

  9. A Study To Evaluate Encorafenib Plus Cetuximab With/without Chemotherapy To Treat Metastatic Colorectal Cancer - Mayo Clinic

    Previous treatment with any selective BRAF inhibitor (e.g., encorafenib, dabrafenib, vemurafenib, XL281/BMS-908662) or any EGFR inhibitor (eg, cetuximab, ...

  10. MCG As A Noninvasive Diagnostic Strategy For Suspected INOCA (MICRO2) - Mayo Clinic

    - Known estimated glomerular filtration rate (eGFR) <30 ml/min. - Known moderate or severe valvular disease (anything besides mild) - Life expectancy <3-yrs ...